U.S. Markets closed

BioNovelus Announces the New Board of Directors

SCOTTSDALE, AZ / ACCESSWIRE / May 11, 2016 / BioNovelus, Inc. (ONOV) is pleased to announce its new Board of Directors. On May 3, 2016, the company held its quarterly Board of Directors meeting with the majority of shareholders present.

"All four of our newest Board members embody the spirit of sustainability: People, Planet, and Profit, and bring talent, expertise, energy and passion to the table," says Jean Ekobo, President/CEO of BioNovelus.

New board members elected for two years include:

Jean Ekobo Chairman of the Board, and President & CEO of BioNovelus, Inc.
Marvin Clark interim Treasurer
Nathalie Ekobo Secretary
Joss Francheterre Board member at-large
Mark Johnson and James Perrine Advisory Board Members

Other matters taken up at the board meeting:

A new transfer Agent is appointed.
The new transfer Agent is Nevada Agency and Transfer Company.
BioNovelus has retained the Law firm of Ryley Carlock & Applewhite.

--------------------------------

About BioNovelus Inc.

BioNovelus, Inc. (ONOV) is a biotech company that honors the environment with an innovative, cost effective, and disruptive technology-based solution to the problems of safety and cleanliness regarding food production and water supply.

------------------------------------------------------------------------------------------------

Additional Information

For additional information: http://bionovelus.com

Please contact: Nathalie Ekobo,
Marketing & Communications Director
BioNovelus, Inc.:
Skype: bionovelus.inc
+1 602-888-3424
NEkobo@BioNovelus.com

Forward-Looking Statements

This news release includes forward-looking statements covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events, they are subject to various risks and uncertainties and actual results for fiscal year 2015 and beyond could differ materially from the Company's current expectations. Forward-looking statements are identified by words such as "anticipates," "projects," "expects," "plans," "intends," "believes," "estimates," "targets," and other similar expressions that indicate trends and future events.

Factors that could cause the Company's results to differ materially from those expressed in forward-looking statements include, without limitation, variation in demand and acceptance of the Company's products and services, the frequency, magnitude and timing of paper and other raw-material-price changes, general business and economic conditions beyond the Company's control, timing of the completion and integration of acquisitions, the consequences of competitive factors in the marketplace including the ability to attract and retain customers, results of continuous improvement and other cost-containment strategies, and the Company's success in attracting and retaining key personnel. The Company undertakes no obligation to revise or update forward-looking statements as a result of new information, since these statements may no longer be accurate or timely.

Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, and are subject to Rule 3B-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this press release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.

SOURCE: BioNovelus Inc.